← Back to Search

ABMT for Social Anxiety Disorder

N/A
Recruiting
Led By Jeremy W Pettit, PhD
Research Sponsored by Florida International University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have no current psychotropic medication other than a stable dose of stimulant or non-stimulant medication for coexisting ADHD
Be between ages 10 and 14 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow-up (six months after completing the final treatment session)
Awards & highlights

Study Summary

This trial is testing a new treatment for social anxiety disorder in 260 youths, ages 10-14. The new treatment is called Attention Bias Modification Treatment (ABMT), and it is administered via computer. The investigators hypothesize that ABMT will be more effective than the current standard treatment, which is called the Neutral Control Task (NCT). The investigators will measure the effectiveness of ABMT using a biomarker of attention to social threat, which is measured using electroencephalography (EEG), and ratings of social anxiety severity.

Who is the study for?
This trial is for youths aged 10-14 with Social Anxiety Disorder, without severe other psychiatric conditions or current psychotropic medication (except for stable ADHD treatment). They must not have a history of neurological illness, significant head injury, uncorrected vision or physical disabilities affecting mouse use, nor meet criteria for certain other disorders.Check my eligibility
What is being tested?
The study tests Attention Bias Modification Treatment (ABMT) against a Neutral Control Task (NCT) in reducing social anxiety. Participants will be randomly assigned to receive one of the two computer-based treatments over eight sessions. The effectiveness will be measured using EEG and social anxiety severity ratings.See study design
What are the potential side effects?
Since ABMT and NCT are non-invasive computer tasks focusing on attention training, they typically do not have direct side effects like medications. However, participants may experience fatigue or frustration during the tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am only taking medication for ADHD and nothing else for mental health.
Select...
I am between 10 and 14 years old.
Select...
I have been diagnosed with Social Anxiety Disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~follow-up (six months after completing the final treatment session)
This trial's timeline: 3 weeks for screening, Varies for treatment, and follow-up (six months after completing the final treatment session) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
P1 amplitude elicited in the dot-probe task
Secondary outcome measures
Liebowitz Social Anxiety Scale for Children and Adolescents
Screen for Child Anxiety Related Emotional Disorders - Child Version at Follow-Up
Screen for Child Anxiety Related Emotional Disorders - Child Version at posttreatment
+2 more
Other outcome measures
State Anxiety before and after a Speech Task

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Attention Bias Modification TreatmentExperimental Treatment1 Intervention
Attention Bias Modification Treatment is a computer-based attention training program.
Group II: Neutral Control TaskPlacebo Group1 Intervention
Neutral Control Task uses the same computer-based format as Attention Bias Modification Treatment, but includes only neutral stimuli and does not train attention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Attention Bias Modification Treatment
2010
N/A
~120

Find a Location

Who is running the clinical trial?

Florida International UniversityLead Sponsor
99 Previous Clinical Trials
17,045 Total Patients Enrolled
Yale UniversityOTHER
1,848 Previous Clinical Trials
2,737,558 Total Patients Enrolled
Jeremy W Pettit, PhDPrincipal InvestigatorFlorida International University

Media Library

Attention Bias Modification Treatment Clinical Trial Eligibility Overview. Trial Name: NCT03932032 — N/A
Social Anxiety Disorder Research Study Groups: Attention Bias Modification Treatment, Neutral Control Task
Social Anxiety Disorder Clinical Trial 2023: Attention Bias Modification Treatment Highlights & Side Effects. Trial Name: NCT03932032 — N/A
Attention Bias Modification Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT03932032 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the maximum number of participants being accepted into this medical research?

"Affirmative. Clinicaltrials.gov documents that this clinical trial, initially posted on July 1st 2019 and most recently modified on November 30th 2021, is actively recruiting for 260 participants from 2 sites."

Answered by AI

Are there still open slots for enrollment in this research endeavor?

"Affirmative, according to information on clinicaltrials.gov this research is recruiting patients. It was initially posted in July 1st 2019 and updated as recently as November 30th 2021. There are 260 participants required between 2 sites for the trial's completion."

Answered by AI

Is this research endeavor open to individuals over 45 years of age?

"This research trial is suitable for children aged between 10 and 14. Moreover, there are 110 studies accessible to minors and 275 available to those over 65 years old."

Answered by AI

Who is entitled to partake in this experiment?

"This clinical study is recruiting 260 minors aged 10-14 with a diagnosis of Social anxiety Disorder. To be accepted, patients must not have any concurrent psychiatric afflictions more serious than SAD and cannot take psychotropic medication other than pre-set doses of stimulant or non-stimulant medications for coexisting Attention Deficit Hyperactivity Disorder."

Answered by AI

Who else is applying?

What site did they apply to?
Yale Child Study Center Program for Anxiety and Mood Disorders
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Targeting Attention Orienting to Social Threat to Reduce Social Anxiety in Youth
2019. "Targeting Attention Orienting to Social Threat to Reduce Social Anxiety in Youth". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03932032.
All > Social Anxiety Disorder > Social Anxiety
~32 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top